“…1,2 Dogs with immune-mediated hemolytic anemia (IMHA), hyperadrenocorticism, those receiving exogenous corticosteroids, protein-losing nephropathies (PLN), various neoplastic and infectious diseases, pancreatitis, and enteropathies are at increased risk of thromboembolic complications from altered platelet activity. [3][4][5][6][7][8][9][10] Antiplatelet medication is often prescribed to reduce the likelihood of clot formation. 2,11,12 Despite antiplatelet medication being considered by many veterinarians as standard of care, the choice of agent and the effective dose in individual animals remain unclear.…”